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Porcine Epidemic Diarrhea Virus
Shedding and Antibody Response in
Swine Farms: A Longitudinal Study
Cristina Bertasio, Enrico Giacomini, Massimiliano Lazzaro, Simona Perulli, Alice Papetti,
Antonio Lavazza, Davide Lelli, Giovanni Alborali and Maria B. Boniotti*
Istituto Zooprofilattico Sperimentale della Lombardia e Dell’Emilia Romagna (IZSLER), Brescia, Italy
The porcine epidemic diarrhea virus (PEDV) causes an acute and highly contagious
enteric disease characterized by severe enteritis, vomiting, watery diarrhea, and a high
mortality rate in seronegative neonatal piglets. In the last few years, PED had a large
economic impact on the swine industries in Asia and the US, and in 2014, the PEDV
also re-emerged in Europe. Two main PEDV variants circulate worldwide but only the
S INDEL variant, considered a mild strain, is spreading in Europe. To gain insights
into the pathogenicity of this variant, its viral load and temporal shedding pattern were
evaluated in piglets from infected farms. Quantitative real-time PCR (qPCR) targeting
the spike gene, was validated according to the minimum information for quantitative
real-time PCR experiments guidelines. The qPCR was applied to longitudinal studies
conducted in four swine farms naturally infected with the PEDV S INDEL variant. Clinical
data, fecal swabs, and blood samples were collected from 103 piglets at 15–30-day
intervals for 2–5 months. On all four farms, diarrhea was observed in sows during
gestation and in farrowing units, and the mortality rates of piglets were 18, 25, 30,
and 35%. Different clinical pictures (0−50% of diarrhea positivity), viral titer levels (mean
5.3−7.2 log10 genome copies/mL), and antibody conditions (30−80% of positivity) were
registered among sows on the four farms. The percentage of qPCR positive piglets
varied greatly from the beginning (63–100%) to the end (0%) of the infection course.
Clinical signs were present in 96% of the qPCR positive animals. Viral loads ranged from
8.5 log10 to 4 log10 genome copies/mL in suckling pigs at 3–6 days of age and were
not statistically different among farms, despite the different patterns observed in sows.
After 2–3 weeks, only a few piglets still showed detectable viral levels and clinical signs,
and they developed antibody responses. Moreover, co-infections with other pathogens
and biosecurity procedures limiting the circulation of the virus could have influenced
the severity of PED infection. QPCR and clinical data were useful in understanding
the dynamics of PEDV infections and, therefore, in implementing appropriate control
measures.
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INTRODUCTION
Porcine epidemic diarrhea virus (PEDV) causes an acute and highly contagious enteric disease,
which is characterized by severe enteritis, vomiting, watery diarrhea and a high mortality rate
in neonatal piglets. Belonging to the family Coronaviridae, genus Alphacoronavirus, PEDV has
a single-stranded, positive-sense RNA genome of ∼28 kb that encodes four structural proteins,
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spike (S), envelope, membrane, and nucleocapsid, and three
nonstructural proteins (Kocherhans et al., 2001). In particular,
the S protein is important in regulating interactions with specific
cell receptor glycoproteins to mediate viral entry, inducing
neutralizing antibodies (Bosch et al., 2003), growth adaptation
in vitro and in virulence attenuation in vivo (Sato et al., 2011).
Since 2010, PED has caused large economic losses in the
swine industries of Asia and North America (USA and Canada)
(Stevenson et al., 2013; Kochhar, 2014). Based on the nucleotide
sequence of the S1 spike gene (Lee, 2015), two main genetic
variants have been detected: a “highly virulent” strain, called
“non-S INDEL (insertions and deletions)” (Vlasova et al., 2014;
Sun et al., 2015), and a “mild” strain, called “S INDEL”, identified
in pigs with mild clinical signs and no mortality (Vlasova et al.,
2014; Wang et al., 2014).
Since 2014, in Europe, the non-S INDEL PEDV strain has been
detected only in the Ukraine (Dastjerdi et al., 2015), while the S
INDEL strain has spread throughout many countries including
Germany, France, Belgium, Portugal and Italy (Grasland et al.,
2015; Hanke et al., 2015; Mesquita et al., 2015; Theuns et al., 2015;
Boniotti et al., 2016). All of the S INDEL PEDV European strains
share 99% nucleotide identity with S INDEL PEDV OH851, but
in contrast with field observation in the USA (Wang et al., 2014),
outbreaks with high mortality rates in suckling piglets have been
reported in Germany (Stadler et al., 2015) and Portugal (Mesquita
et al., 2015).
In Italy, PED has been documented since 1997, with a
few cases appearing per year. However, between 2005 and
2006, a severe PEDV epidemic occurred in Italy (Martelli
et al., 2008), which was characterized by mortality rates in
neonatal piglets of up to 34%, whereas it was very low in
adults. During 2007–2012, only sporadic confirmed clinical
cases of PED were reported (Boniotti et al., 2016). During
this period, two swine coronavirus clades were identified.
The first resembled the oldest global PEDV strain CV777
(PEDV/Italy/7239/2009) and the second resembled a new
Transmissible Gastroenteritis Coronavirus/PEDV recombinant
variant (SeCoV/Italy/213306/2009). During summer 2014,
animals on two farms displaying mild clinical signs were detected
as positive for PEDV by PCR (Boniotti et al., 2016), and at the
beginning of 2015 a new severe epidemic wave occurred (Efsa
Ahaw Panel, 2014).
Recently, the virulence of the S- INDEL strain has been
evaluated and compared to the non-S INDEL strain through
experimental infections (Lin et al., 2015; Yamamoto et al., 2015;
Chen et al., 2016). In one study, 5-day-old piglets inoculated with
an S INDEL PEDV strain (USA/IL/2014/20697) did not develop
clinical signs and had only mild histopathological lesions (Chen
et al., 2016). Lin et al. (2015) showed that the virulence of the
S INDEL PEDV strain was lower than the non-S INDEL US
PEDV based on a longer incubation time, a shorter duration of
diarrhea, a lower percentage of infected enterocytes and a lower
piglet mortality rate. However, the severity of clinical signs and
mortality rates (0–75%) varied greatly among litters inoculated
with the S INDEL strain. These variations were associated with
piglet birth weights and the sow’s health and lactation status (Lin
et al., 2015).
To evaluate differences in morbidity and the virulence of
the S INDEL strains, field data are extremely important, as
many concurrent factors, not reproducible in an experimental
infection, can determine the infection severity. Presently, the
limited available field observations (Wang et al., 2014; Mesquita
et al., 2015; Stadler et al., 2015) indicated that the virulence level
of S INDEL PEDV varied greatly. The different immunological
states of infected piglets, due to lactogenic immunity, is a likely
explanation of such variations.
Viral load is an important indicator in evaluating the virulence
of a strain and the susceptibility of infected animals, and
in understanding the mechanisms of viral transmission and
circulation within the different farm units. At the moment, very
limited data have been published on the PEDV viral load during
an outbreak under field conditions (Bjustrom-Kraft et al., 2016).
In this study, we describe acute outbreaks of PED in three
farrow-to-finish and one farrow-to-wean farms in Northern Italy.
We conducted a longitudinal study by sampling the feces and
blood of piglet groups from each farm at fixed intervals during
a 2–5 months period, and then we determined PEDV shedding
and the antibody presence. In particular, the quantification of
PEDV in fecal samples was used to better describe the infection
dynamics under field conditions.
MATERIALS AND METHODS
Farms
Three farrow-to-finish and one farrow-to-wean farms located in
the north of Italy were chosen for this study, which occurred from
January to May 2015. Farms were selected based on the following
criteria: location in the high density swine production area of
the Po Valley, a short distance from the diagnostic laboratory to
facilitate the conservation of samples and quick delivery, sudden
onset of enteric clinical signs, mortality in newborn piglets clearly
referable to PED and an absence of an anamnesis of PED on the
farm.
In Table 1, data on the four farms are summarized. The
PED clinical and epidemiological characteristics, as well as the
disease course, for the four farms are recorded in Supplementary
Table 1. At each sampling time, clinical evaluations of the
farms were determined by vets from our Institute, recording the
percentages, in four ranges, low (0–5%), medium (6–20%), high
(21–50%), and very high (>50%), of diarrheic pigs among the
different farm units (Supplementary Table 2). Fecal consistency
was visually evaluated and scored using the following criteria:
0= normal, 1= formed and soft, 2= semi-solid, 3=watery, and
4 = presence of mucus and blood. The maximum observed fecal
score attributed to each farm unit was recorded at each sampling
time and reported in Supplementary Table 2.
Longitudinal Study
At 3–28 days from the first appearance of clinical signs on the four
farms (F1−F4), 10 sows per farm, and 19, 24, 30, and 30 newborn
piglets from F1, F2, F3, and F4, respectively, were selected
from symptomatic litters, identified by ear tag and sampled
every 2 weeks (samplings 1–3), 4−5 weeks (samplings 4−5) and
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TABLE 1 | Farm production type, onset of outbreak, mortality rate, and animals enrolled in the longitudinal study.
Farm Type No. of sows Onset of outbreak % Mortality rate in suckling piglets No. sampled animals
Date Unit Sows Piglets
1 Farrow-to-finish 350 Jan-08 Fattening 25 10 19
2 Farrow-to-finish 350 Jan- 06 Fattening 30 10 24
3 Farrow-to-finish 650 Feb-15 Gestation 35 10 30
4 Farrow-to-wean 250 May-18 Delivery room 18 10 30
after 7 weeks (sampling 6). The number of sampled animals
decreased as the study continued due to mortality and animal
sales (Supplementary Table 3). The sows were sampled only once
at the beginning of the study. The presence of diarrheic piglets
was recorded at each sampling time (Supplementary Table 3).
PEDV RNA Extractions
Fecal and blood samples were collected from sows, whereas blood
and rectal swabs were collected from piglets. Feces were diluted
1:10 (w/v) in minimum essential media (MEM). Rectal swabs
were suspended in 1 mL of MEM, vortexed and incubated at
4◦C for 30 min to allow the release of the feces from the cotton.
Fecal suspensions were clarified by centrifugation for 10 min at
4,000× g to eliminate fecal debris.
Viral RNA was extracted from 200 µL of sample using
a commercial kit (NucleoMag R© Vet kit, Macherey-Nagel,
Düren, Germany), according to the manufacturer’s instructions.
An exogenous internal control RNA (IC) (Qiagen, Hilden,
Germany), was added to specimens prior to RNA extraction to
verify the success of the procedure and the absence of inhibitors.
The extraction was carried out on the Biosprint 96 instrument
(Qiagen) using the NucleoMag Vet 200 protocol. Nucleic acids
were eluted into 100 µL of elution buffer and immediately
subjected to RT-PCR or stored at−80◦C until used.
PEDV qRT-PCR Assay
Extracted viral RNA was subjected to a “one-step” RT-PCR assay
using the commercial Quantifast Pathogen RT-PCR kit (Qiagen)
with primers and probe targeting the S1 gene of PEDV that were
previously developed at the University of Minnesota Veterinary
Diagnostic Laboratory (2014), and are reported in Table 2. The
optimum concentrations of primers and probe were deduced by
titration experiments and are reported in Table 2. PCR reactions
were performed on 5 µL of extracted viral RNA in a final volume
of 25 µL, which also contained 5 µL of 5× PCR-master mix,
2.5µL of a 10× internal control assay, 2.5µL of each forward and
reverse primer (final concentration 500 nM), 0.5 µL of PED_S
probe (final concentration 200 nM), and 0.25 µL of enzyme mix.
The PEDV RNA was reverse transcribed at 50◦C for 20 min,
followed by 1 cycle of Taq polymerase activation at 95◦C for
5 min. Amplification consisted of 45 cycles at 95◦C for 15 s
and 60◦C for 30 s. Amplification were performed on a CFX96
Touch Real-Time PCR Detection System (Bio-Rad Laboratories)
and data were analyzed with the Software Bio-Rad CFX Manager
3.1, using the single threshold method for the Cq determination.
An experiment was accepted when the Cq of the “no template
control” (NTC) was >40 and the IC of a negative control was
<35.
Generation of the Standard Curve
We cloned a fragment of the S1 gene (nucleotide positions
1503–2153; GenBank DQ985739.1) into a pCR R© 2.1-TOPO R©
vector (TOPO TA Cloning R© kit, Invitrogen) according to the
manufacturer’s instructions. Plasmid DNA was linearized by
restriction enzyme digestion and then subjected to transcription
using the RiboMax Large Scale RNA Production System
(Promega) to produce an RNA transcript.
The RNA concentration was determined using an Infinite R©
200 NanoQuant spectrophotometer (Tecan). A 10-fold serial
dilution in nuclease-free water of ssRNA transcripts (2 × 106 –
2× 102 copies/µL) was used to generate a standard curve and to
quantify PEDV RNA in the samples. Triplicates of each dilution
were run in each assay. The following equation:
x = 10
Cq−(y intercept)
slope , (1)
where x represents the genome copies/µL, was used to transform
the samples’ Cq values into estimates of genome copies of PEDV
RNA per mL of fecal homogenate.
qRT-PCR Performance Parameters
The qPCR assay used to quantify PEDV RNA was validated
according to the minimum information for quantitative real-
time PCR experiments guidelines (Bustin et al., 2009). Validation
results are summarized in Table 3.
Specificity
To ascertain the specificity of the qPCR used in this study, we
tested eight samples that were negative for PEDV and positive
for different viral agents, including Transmissible Gastroenteritis
Coronavirus, Rotavirus, Avian Influenza Virus H1N1, Reovirus,
Encephalomyocarditis virus, Parvovirus, Suid Herpesvirus 1, and
Porcine Reproductive and Respiratory Syndrome virus. The PCR
assay amplified and detected only the intended virus (PEDV)
and there was no evidence of viral cross-detection. Specificity
is expressed as the percentage of negative reactions among the
tested samples.
Limit of detection (LOD), limit of quantification (LOQ), and
linearity
The limit of detection (LOD) and limit of quantification (LOQ)
were determined by testing 10 replicates of a 10-fold serial
dilution of ssRNA transcript, from an initial concentration of
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TABLE 2 | Primer/probe sequences and concentrations (nM) used in quantitative real-time PCR (qPCR) assay.
Sequence (5′-3′) nt position∗ Conc
PED_S for ACGTCCCTTTACTTTCAATTCACA 1846–1869 500
PED_S rev TATACTTGGTACACACATCCAGAGTCA 1931–1957 500
PED_S Probe FAM-TGAGTTGATTACTGGCACGCCTAAACCAC-BHQ1 1875–1903 200
∗According to the published sequence of the porcine epidemic diarrhea virus (PEDV) S1 gene, GenBank accession number DQ985739.1.
TABLE 3 | Performance parameters of the PEDV qPCR assay.
Test Result
Mean slope of four replicate
standard curve
−3.3343
Calibration curve, R2 0.996
PCR Efficiency 99.5%
Linear dynamic range 2 × 100−2 × 108 genome copies/µL
Specificity 100%
LOD 2 genome copies/µL
LOQ 20 genome copies/µL
Cq variation at LOD 1.72%
Repeatability ±9.83% to ±12.75%
Reproducibility 12.82% (±7.85 to ±17.57)
Inhibition assay 3.15 cycles
R2, linear correlation index; LOD, limit of detection; LOQ, limit of quantification.
2 × 105 to a final concentration of 2 × 10−2 genome copies/µL
(Supplementary Table 4). The LOD was calculated as the lowest
concentration at which 100% of the positive samples are detected.
The LOQ was defined as the lowest concentration of viral
RNA that can be determined with acceptable precision (relative
standard deviation≤25%) under the stated conditions of the test.
The linear correlation index (R2) and the slope of the
calibration curve were calculated using mean values from three
replicates of four different runs. The reaction efficiency (E) under
our experimental conditions was determined by the following
formula:
E = (10 −1slope − 1)× 100%.
The dynamic range was determined by testing three replicates
of a 10-fold serial dilution of ssRNA transcript, from an initial
concentration of 2 × 108 to a final concentration of 2 × 100
genome copies/µL (Supplementary Figure 1).
Repeatability (Intra-assay Variance) and Reproducibility
(Inter-assay Variance)
Repeatability was evaluated by analyzing three PEDV positive
samples in triplicate in the same extraction and qPCR run
(Supplementary Table 5). Intra-assay variance was expressed as
the range of the relative standard deviation (RSD%) associated
with copy number/µL. Reproducibility was determined by testing
three PEDV-positive samples having different concentration
levels. Samples were extracted and quantified on four different
days (Supplementary Table 6). Inter-assay variance was expressed
as mean RSD% with minimum and maximum values of copy
numbers at each concentration level, calculated for the different
concentration levels.
Inhibition assay
To verify the absence of contaminants that can cause the
inhibition of qPCR assays after the RNA extraction procedure,
the extracted RNAs of 10 specimens were diluted 1:10 (v/v) in
water and subjected to qRT-PCR. Inhibition was evaluated by
calculating the differences in mean Cq values between diluted and
undiluted samples.
S1 PEDV Gene Sequencing
The S1 gene sequences of PEDV positive samples on farm 1, were
obtained from one sow and one piglet at the first sampling and
from three piglets at 61 days of age, as described by Boniotti et al.
(2016) (accession number: KY009940-KY009941).
PEDV ELISA for Antibody Detection
An in-house PEDV whole virus ELISA was used. In brief, a
PEDV strain CV777-based ELISA was developed and validated
at IZSLER based on the previously described double-antibody
sandwich ELISA protocol (Sozzi et al., 2010). The ELISA
microplates were coated with the 1F12 capture monoclonal
antibody (MAb). Serum samples diluted 1:2 or 1:4 were
mixed with equal volumes of whole PEDV inactivated with
ß-propiolactone and pre-incubated in an auxiliary microplate for
1 h at 37◦C. Then, 50 µL of the pre-incubated mixtures were
transferred into the 1F12 MAb-coated plate and the conjugated
horseradish peroxidase MAb 4C3 was added. Following a
further 1h incubation at 37◦C, the plate was washed. The
colorimetric reaction was performed, and optical densities (OD)
were measured at 492 nm using an ELISA plate reader. Results
were calculated by determining the absorbance value reduction,
expressed as percentage of inhibition (PI) using the control wells
as the reference. The antibody-blocking reaction was considered
positive if the PI was ≥60%.
Co-infections
For differential diagnoses and to investigate concomitant
infections, fecal and serum samples were further investigated
to detect Transmissible Gastroenteritis Coronavirus, Porcine
Deltacoronavirus, swine Rotavirus A, B, C, and H, Porcine
Reproductive and Respiratory Syndrome Virus; Influenza A
Virus, Escherichia coli, Clostridium perfringens, and Salmonella
typhimurium, as previously described (Kim et al., 2001; Marthaler
et al., 2014a,b).
Statistical Analyses
Statistical analyses were performed on quantitative data from
fecal specimens of the first sampling both in sows and piglets,
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using the Kruskal−Wallis test and Dunn’s multiple comparisons
test (GraphPad InStat Prism 6.0 software).
RESULTS
Farm Clinical Assessments
At the beginning of the S INDEL PEDV epidemic wave in
Northern Italy (January 2015), four farms with symptoms
referable to PED were selected for a longitudinal study. Farm
production type, onset of outbreak, mortality rate in suckling pigs
and sampled animals for each farm, were described in Table 1.
Severe clinical signs were observed during these outbreaks
(Supplementary Table 1), with mortality rates in suckling piglets
of 25, 30, 35, and 18% on F1, F2, F3, and F4, respectively
(Table 1). PEDV quickly spread within F1, F2, and F3 to all of
the units, but on F4 it only reached the gestation and delivery
room (Supplementary Table 2). Watery diarrhea with presence of
mucus and blood was observed in piglets of the four farms, but
it was also present in gestation and farrowing sows. Growing and
fattening animals from F1, F2, and F3 also showed severe clinical
signs including watery diarrhea and anorexia. Vomiting was
observed in fattening animals on F1. Dehydration was observed
in litters on F1 and F3 and cachexia in litters on F1 and F4.
Agalactia was present in the sows from F1, F2, and F3.
For differential diagnoses and to investigate concomitant
infections, which potentially could impact the evolution of
clinical signs and the course of the disease, fecal and serum
samples were further investigated to detect other viral and
bacterial pathogens. Rotavirus A was present in both the sows
and piglets of F3, E. coli, expressing the virulence factor F4, in
F2 and F3, C. perfringens in F1 and F3, and S. typhimurium in F3.
However, no clinical signs, referable to a specific enteric disease,
were present before the beginning of the longitudinal study.
Longitudinal Study Outcomes
Symptoms
At the first sampling, watery diarrhea or soft diarrhea was
observed in 30% (3/10), 0% (0/10), 50% (5/10), and 40% (4/10)
of the sows from F1, F2, F3, and F4, respectively (Table 4).
At the same time high percentages (68–100%) of 3–6-day-old
piglets were observed to have diarrhea on all of the farms
(Table 5). Clinical symptoms in piglets progressively disappeared
at the following sampling times. However, a second outbreak of
diarrhea was observed in 3 out of 16 animals (19%) at two months
of age on F1.
PEDV RNA Detection in Sows
Samples were only taken from sows at the initial sampling time,
which occurred at 7, 28, 3, and 19 days after the onset of
symptoms on F1, F2, F3, and F4, respectively. PEDV RNA was
detected in 8/10 sows on F1, 8/8 sows on F2, 10/10 on F3 and
7/10 on F4 (Table 4). The highest fecal PEDV RNA shedding
titers were detected on F2 and F3 (8.3 and 7.6 log10 genome copies
per mL of fecal homogenate), with a mean titer among shedding
animals of 6.5 and 7.2 log10 copies/mL, respectively (Figure 1A).
Mean lower titers were observed in F1 and F4 animals (5.3 and
5.4 log10 copies/mL, respectively) where the highest titers were
6.4 and 6.5 log10 copies/mL, respectively.
PEDV RNA Detection in Piglets
The fecal viral shedding in piglets from the four farms is
summarized in Table 5 and Figure 1B. All of the farms had a
similar virus-shedding pattern, with high percentages of PEDV
PCR positive 3–6-day-old animals (Sampling 1) that decreased in
14–18-day-old animals (Sampling 2) and was no longer present
in 30–36-day-old animals (Sampling 3) to the end of the study
period (Table 5). Furthermore, on F1, a second peak of viral
shedding was detected in weaning piglets at 61 days of age
(Sampling 4). Two weaning piglets did not show detectable viral
shedding in the previous samplings. Interestingly, the presence
of different strains was assessed by sequencing the S1 gene of
positive samples collected at the first and forth samplings. Two
genetic variants with a single amino acid substitution (156E>G)
were detected at Samplings 1 and 4. On F2, 87.5% of 3-day-old
piglets were PCR positive, four of them (16.7%) were positive
at 18 days of age (Sampling 2) and only one animal was still
positive at 32-days old (Sampling 3). Moreover, one pig showed
intermittent PEDV shedding, being PCR positive at the first
sampling (3 days after birth), negative at 18- and 32-days old
(Samplings 2 and 3, respectively) and again positive at 67-days
old (Sampling 4) (Supplementary Table 3). On F3, all of the 4-
day-old piglets were PCR positive using rectal swab samples but
only three of them remained positive at 17-days old (Sampling
2). At the following sampling times, when they were 36- and 72-
days old, they were all PCR negative. On F4, 86.7% of 3-day-old
piglets were PCR positive but viral shedding was not detected
in 30-day-old piglets through the end of the study. The highest
fecal PEDV RNA shedding titer was observed in 3–6 day-old
piglets with mean values (among shedding animals) of 5.9, 5.6,
5.6, and 6.2 log10 copies/mL on F1, F2, F3, and F4, respectively
(Figure 1B; Supplementary Table 3). No significant differences
were statistically evident among the farms. The titer values
observed in 14–18-day-old piglets were 5.9 (one animal), 4.8
(mean value of two animals), 4.9 (mean value of three animals)
log10 copies/mL on F2, F3, and F4, respectively (Supplementary
Table 3).
PEDV Antibody Detection in Sows and Piglets
PEDV-antibodies were detected in 8/10, 7/10, 3/10, and 3/9 sows
on F1, F2, F3, and F4, respectively (Table 4). In newborn piglets,
PEDV-antibodies were detected in 26, 4, 0, and 20% of animals
from F1, F2, F3, and F4, respectively (Table 5). In total, 54% of
the sows had anti-PEDV antibodies at delivery but only a few
piglets (3%) showed detectable antibodies and a lack of clinical
signs at 3–6 days of age. Most of the piglets on the four farms
developed antibody responses within 3 weeks of age, and they
remained stable until the end of the study (60–100 days of age).
DISCUSSION
In the last few years, PED had a large economic impact on the
swine industries in Asia and the US, and in 2014, the PEDV
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TABLE 4 | Diarrhea, PEDV detection in fecal samples, and cELISA results of sows.
FARM 1 FARM 2 FARM 3 FARM 4
Sow ID Diarrhea qRT-PCR cELISA Diarrhea qRT-PCR cELISA Diarrhea qRT-PCR cELISA Diarrhea qRT-PCR cELISA
1 + + + − + + + + − − + −
2 − + − − + + + + − + + −
3 − + + − + + − + − − + +
4 + + + − + + + + − + − −
5 − + + − NA + − + − − + −
6 − − − − + + + + − − + −
7 − − + − + − − + + + − +
8 − + + − + + + + + − − +
9 + + + − NA − − + − + + −
10 − + + − + − − + + − + NA
+, presence/positive; −, absence/negative; NA, not available (missing sample).
TABLE 5 | Diarrhea, PEDV detection, and cELISA results for animals from 3 to 145 days of age.
Farm Samplings (S) No. of animals Age (day) Positivity (%) No. animals∗
Diarrhea qRT-PCR cELISA Died NA
1 1 19 6 68.4 63.2 26.3 − −
2 18 23 N/A N/A 88.9 1 −
3 17 33 5.9 0 100 1 −
4 16 61 18.8 18.8 100 − 1a
5 12 97 0 8.3 100 − 5b
6 8 145 0 0 100 − 4b
2 1 24 3 100 87.5 4.2 − −
2 24 18 29.2 16.7 91.7 − −
3 24 32 8.3 4.2 100 − −
4 20 67 0 5 90 3 1a
5 18 103 0 0 82.4 − 2b
3 1 30 4 100 100 0 − −
2 30 17 10 10 83.3 − −
3 29 36 0 0 96.6 1 −
4 15 72 0 0 93.3 − 14b
4 1 30 3 90 86.7 20 − −
2 22 14 36.4 22.7 95.5 5 3a
3 22 30 0 0 86.4 − −
4 21 63 0 0 81 4 6a
*Animals died or were not available (NA). The number of sampled animals decreased as the study continued due to mortality, earmarks lost (NAa), and animal sales (NAb).
also re-emerged in Europe. Two main PEDV variants circulate
worldwide but only the S INDEL variant, considered a mild
strain, is spreading in Europe. During summer 2014, animals with
mild clinical signs on two farms were detected as PCR positive
for PEDV in Northern Italy (Boniotti et al., 2016). Thereafter,
a new severe PED epidemic wave occurred. To gain insights
into the pathogenicity of this variant, we described the results of
a longitudinal study conducted during acute outbreaks of PED
in three farrow-to-finish (F1−F3) and one farrow-to-wean farm
(F4), occurred in the beginning of 2015.
On the four farms, the mortality rates of suckling piglets were
high (25, 30, 35 and 18% on F1, F2, F3 and F4, respectively)
(Table 1). However, they did not reach the percentages observed
in the US, caused by the original PEDV strain (>50%) (Alvarez
et al., 2015). Moreover, the four farms showed high percentages
(21−50,>50%) of diarrheic animals, in particular, in all the units
of the F1, in piglets of F2 and in sows and piglets of F3 and F4,
but differences among farms were also observed. The course of
PED was particularly severe on F1, where we observed a high
percentage of animals with diarrhea in suckling, weaning and
fattening animals (Supplementary Table 2). Moreover, the virus
appeared to circulate longer on this farm since positive animals
were detected even 60 and 100 days after the first PEDV detection
within the farm. In particular, at 60 days of age a second peak
of viral shedding was observed in three animals. The S1 gene
sequences of the strain identified in these animals showed a
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FIGURE 1 | Fecal porcine epidemic diarrhea virus (PEDV) RNA shedding of sows (A) and of 3–6-day-old piglets (B) in each farm as determined by qRT-PCR.
Individual viral titers are expressed as log10 genome copies/mL. Limit of detection (LOD) and limit of quantification (LOQ) values are indicated.
different genetic variant compared with the strain circulating at
the onset of the clinical signs. Thus, an additional introduction
of a second viral strain likely occurred. Such a situation, as
well as the quick spread of PEDV on one farm to the different
units, could be the direct consequence of the application of poor
biosecurity measures, incorrect management and/or the limited
efficacy of disinfection procedures.
The different patterns and severity of clinical signs observed
on the four farms may have resulted from the concurrent effects
of co-infections with other pathogens. In particular, Rotavirus,
with a well-known pathogenic aptitude, which is mainly dose-
dependent, could have had a synergistic effect with PEDV on F3,
causing a slight change in the course of the disease in sows and
litters after the first week, and predisposing animals to secondary
infections, such as those caused by E. coli F4, C. perfrigens, and
S. typhimurium.
In this study, we determined the fecal PEDV shedding in sows
and in their piglets from 3 to 6 days to 60−100 days of age.
In particular, we selected groups of 10 sows and 19–30 piglets
on each farm. None of the farms had reported PEDV infections
prior to this study, and thus, we can surmise that the sows had
been recently infected at the time of their enrollment in the
study, while piglets were infected after birth, through contact with
infected sows. More than 80% of the sows showed detectable
levels of PEDV at the first sampling but only the 30% showed
diarrhea. The severity of clinical signs caused by PEDV is age-
dependent (Jung et al., 2016). In adult animals, clinical signs
are usually milder or completely absent. Moreover, in our study,
PEDV exposure dose and the gestational stage of the sows could
have influenced their health status at the moment of delivery
in terms of clinical signs, viral loads and PEDV antibody level.
On F1 and F2, where the onset of PEDV symptoms occurred
in the fattening unit, 8 and 7 out of 10 sows, respectively, had
PEDV antibodies. On F3, where the onset of PEDV symptoms
occurred during the gestation period, 5 out of 10 sows had
diarrhea but only 3 had already developed PEDV antibodies. On
this farm, all of the sows showed high mean viral loads (7.2 log10
copies/mL) as determined by PEDV RNA. Sows on F3 probably
had less time to develop antibodies and transmit them to their
litters through the colostrum. In fact, all of the piglets were
infected and showed high titers of PEDV RNA in fecal materials.
Similarly, on F4, where the onset of the outbreak took place in the
delivery room, 3 out of 9 sows showed detectable levels of PEDV
antibodies.
At the first sampling, a high percentage (63–100%) of the
3–6-day-old piglets from all of the farms were positive by
qPCR. Despite the different immunity levels among the sows
on the four farms, and the different proportions of infected
piglets, the quantitative PEDV RNA results in piglets were not
statistically different among farms. As proposed by other authors,
we assumed that once the pigs were infected and viral replication
began, the initial viral dose appeared to have little impact, at the
group level, on the average amount of fecal shedding (Thomas
et al., 2015).
At 2 weeks of age, the proportion of PCR positive piglets
decreased to 10–22.7%, and at 1 month of age only one animal
was positive. The PEDV RNA titer also decreased with time,
confirming that PED is characterized by high PEDV fecal
shedding titers a few days post infection and the titers tend to
decrease after 1 week. Intermittent shedding can be observed
until 60 days post infection, as shown in F1 and F2, and such
variations in excretion levels and viral loads could be determined
by poor management and a lack of biosecurity measures, but it
could also be due to a new introduction of the virus, as likely
occurred on F1.
For immunity responses, 100% of the animals on F1 showed
detectable levels of PEDV antibodies up to the end of the
study (145 days of age). On F2, F3, and F4, the percentage of
seropositive animals decreased slightly starting from 80 days
of age. The longer and biphasic circulation of the virus on
F1 might have favored subsequent exposures of the animals
to the virus, and thus, a more durable immunity. The likely
outcome of a massive outbreak of PEDV within one herd
is a diffuse and long-lasting immunity. Indeed, especially in
farrow-to-finish farms, such herd immunity and, particularly, the
maintenance of seropositive sows could be an important tool to
prevent severe cases of PED in newborn piglets by transferring
passive maternal immunity with colostrum. Goede et al. (2015)
reported that durable lactogenic immunity was present in sows
previously exposed (7 months) to a S INDEL strain of PEDV
and that this immunity induced cross-protection to an original
virulent PEDV. Cumbersomely, in this study we did not plan to
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investigate the presence of maternal antibodies (IgG and IgA)
in the colostrum or to register the piglets’ birth weight, two
important factors influencing the protective maternal immunity.
However, considering the high percentage of diarrheic and PEDV
positive piglets, and the presence of clinical signs in animals
of different ages, including sows, we can suppose that these
farms were originally naïve with regard to PEDV infection,
and thus the lactogenic antibodies were not present at all, or
anyway sufficient to effectively protect piglets from infection.
Thus, future management of PEDV infection in farrow-to-finish
or farrow-to-wean farms cannot disregard to periodically check
and evaluate the IgA and IgG titers in sow sera and in the
colostrum.
CONCLUSION
Determining the viral loads and shedding rates of PEDV in
real field situations during outbreaks is important in evaluating
the virulence of a strain and in predicting the susceptibility
of infected animals, at different ages and in the various
farm units, within a herd. At the moment, very limited
data have been published on the PEDV viral load during
an outbreak under field conditions (Bjustrom-Kraft et al.,
2016). The qPCR assay used in this study was validated
according to the minimum information for quantitative real-
time PCR experiments guidelines (Bustin et al., 2009; Table 3;
Supplementary Table 7). The method validation is an important
requirement to allow the comparison of quantitative results
from different studies, which would be otherwise difficult to
achieve.
Moreover, understanding the mechanisms of viral
transmission and circulation within the farm can be useful in
implementing appropriate control measures on the farm to
limit the infections spread. Considering the ability of PEDV
to be dispersed rapidly through fecal contamination, particular
attention should be paid to biosecurity and hygiene measures,
such as the proper disinfection of equipment and sites, manure
disposal, suitable procedures for the movements of animals
within the farm, and the use of disposable clothes and shoes
for personnel, staff and visitors.
Longitudinal field studies examining natural infections
are comparatively uncommon amongst reports of PEDV
in comparison to the several experimental studies already
performed. In fact, many unforeseen events can adversely
affect the success of this kind of study: dead of animals,
lost of the earmark, selling or moving of the animals due to
unexpected need of the farmer. These practical hitches could
negatively influence the sampling procedures (e.g., respect of
time points) and data registration. Therefore, by planning
these “observational” studies, so tight inclusion criteria cannot
be established and limited field data could be successfully
registered. On the other hand, the longitudinal studies, directly
conducted in natural outbreaks, are inclusive of the several
“farm factors and field effects” which are very difficult to
reproduce in experimental trials, and thus, the obtained results,
being more reliable and adherent to real conditions could
be effectively used in risk analysis and for defining control
strategies. In conclusion, longitudinal studies conducted under
field conditions during and after a PED outbreak could be
useful in determining the level of immunity acquired at the
herd level and may be integrated with the data acquired
from experimental infections. They provide an added value,
in the possibility to study and evaluate the effects of co-
factors, such as other infectious agents, and management and
environmental conditions, on the evolution and epidemiology of
the disease.
ETHICS STATEMENT
The study was exempt of ethical approval procedures because
animal samplings were performed during the routinely
diagnostic procedures in naturally infected farms.
AUTHOR CONTRIBUTIONS
Performed experiments: CB, EG, ML, SP. Analyzed data: CB.
Conceived and designed experiments: All authors. Wrote and
revised the paper: MB, CB, AL, GA. All authors have approved
the final version of the article.
FUNDING
This work was funded by the Italian Ministry of Health (project
PED_SURV- E52I14001210001 and project PRC2014005).
ACKNOWLEDGMENTS
We thank Anna Mangeli for the skilled technical assistance and
Federico Scali for the statistical analysis. Thanks also to Science
Docs for the English language editing of this manuscript.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fmicb.
2016.02009/full#supplementary-material
REFERENCES
Alvarez, J., Sarradell, J., Morrison, R., and Perez, A. (2015). Impact of porcine
epidemic diarrhea on performance of growing pigs. PLoS ONE 10:e0120532.
doi: 10.1371/journal.pone.0120532
Bjustrom-Kraft, J., Woodard, K., Gimenez-Lirola, L., Totolo, M.,
Wang, C., Sun, Y., et al. (2016). Porcine epidemic diarrhea
virus (PEDV) detection and antibody response in commercial
growing pigs. BMC Vet. Res. 12:99. doi: 10.1186/s12917-016-
0725-5
Frontiers in Microbiology | www.frontiersin.org 8 December 2016 | Volume 7 | Article 2009
fmicb-07-02009 December 15, 2016 Time: 11:12 # 9
Bertasio et al. PEDV Shedding and Antibody Response
Boniotti, M. B., Papetti, A., Lavazza, A., Alborali, G., Sozzi, E., Chiapponi, C., et al.
(2016). Porcine epidemic diarrhea virus and discovery of a recombinant swine
enteric coronavirus. Italy. Emerg. Infec. Dis. 22, 83–87. doi: 10.3201/eid2201.
150544
Bosch, B. J., Van der Zee, R., de Haan, C. A. M., and Rottier, P. J. M. (2003).
The coronavirus spike protein is a class I virus fusion protein: structural and
functional characterization of the fusion core complex. J. Virol. 77, 8801–8811.
doi: 10.1128/JVI.77.16.8801-8811
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M.,
et al. (2009). The MIQE guidelines: minimum information for publication of
quantitative real-time PCR experiments. Clin. Chem. 55, 611–622. doi: 10.1373/
clinchem.2008.112797
Chen, Q., Gauger, P., Stafne, M., Thomas, J., Madson, D., Huang, H., et al.
(2016). Pathogenesis comparison between the United States porcine epidemic
diarrhoea virus prototype and S-INDEL -variant strains in conventional
neonatal piglets. J. Gen. Vir. 97, 1107–1121. doi: 10.1099/jgv.0.000419
Dastjerdi, A., Carr, J., Ellis, R., Steinbach, F., and Williamson, S. (2015). Porcine
epidemic diarrhea virus among farmed pigs. Ukraine. Emerg. Infect. Dis. 21,
2235–2237. doi: 10.3201/eid2112.150272
Efsa Ahaw Panel (2014). Scientific Opinion on porcine epidemic diarrhea and
emerging pig deltacoronavirus. EFSA J. 12,
Goede, D., Murtaugh, M. P., Nerem, J., Yeske, P., Rossow, K., and Morrison, R.
(2015). Previous infection of sows with a “mild” strain of porcine epidemic
diarrhea virus confers protection against infection with a “severe” strain. Vet.
Microbiol. 176, 161–164. doi: 10.1016/j.vetmic.2014.12.019
Grasland, B., Bigault, L., Bernard, C., Quenault, H., Toulouse, O., Fablet, C., et al.
(2015). Complete genome sequence of a porcine epidemic diarrhea S gene indel
strain isolated in France in december 2014. Genome Announc. 3, e535–e515.
doi: 10.1128/genomeA.00535-15
Hanke, D., Jenckel, M., Petrov, A., Ritzmann, M., Stadler, J., Akimkin, V., et al.
(2015). Comparison of porcine epidemic diarrhea viruses from Germany and
the United States, 2014. Emer. Infect. Dis. 21, 493–496. doi: 10.3201/eid2103.
141165
Jung, K., Hu, H., and Saif, L. J. (2016). Porcine deltacoronavirus infection: etiology,
cell culture for virus isolation and propagation, molecular epidemiology and
pathogenesis. Virus Res. 226, 50–59. doi: 10.1016/j.virusres.2016.04.009
Kim, S. Y., Song, D. S., and Park, B. K. (2001). Differential detection of transmissible
gastroenteritis virus and porcine epidemic diarrhea virus by duplex RT-PCR.
J. Vet. Diagn. Invest. 13, 516–520. doi: 10.1177/104063870101300611
Kocherhans, R., Bridgen, A., Ackermann, M., and Tobler, K. (2001). Completion of
the porcine epidemic diarrhoea coronavirus (PEDV) genome sequence. Virus
Genes 23, 137–144. doi: 10.1023/A:1011831902219
Kochhar, H. S. (2014). Canada: Porcine epidemic diarrhea in Canada: an emerging
disease case study. Can. Vet. J. 55, 1048–1049.
Lee, C. (2015). Porcine epidemic diarrhea virus: an emerging and re-emerging
epizootic swine virus. Virol. J. 12, 193. doi: 10.1186/s12985-015-0421-2
Lin, C., Annamalai, T., Liu, X., Gao, X., Lu, Z., El-Tholoth, M., et al. (2015).
Experimental infection of a US spike-insertion deletion porcine epidemic
diarrhea virus in conventional nursing piglets and cross-protection to the
original US PEDV infection. Vet. Res. 46:134. doi: 10.1186/s13567-015-
0278-9
Martelli, P., Lavazza, A., Nigrelli, A., Merialdi, G., Alborali, L., and Pensaert, M.
(2008). Epidemic of diarrhoea caused by porcine epidemic diarrhoea virus in
Italy. Vet. Res. 162, 307–310. doi: 10.1136/vr.162.10.307
Marthaler, D., Homwong, N., Rossow, K., Culhane, M., Goyal, S., Collins, J., et al.
(2014a). Rapid detection and high occurrence of porcine rotavirus A, B, and C
by RT-qPCR in diagnostic samples. J. Virol. 209, 30–34. doi: 10.1016/j.jviromet
.2014.08.018
Marthaler, D., Raymond, L., Jiang, Y., Collins, J., Rossow, K., and Rovira, A.
(2014b). Rapid detection, complete genome sequencing, and phylogenetic
analysis of porcine deltacoronavirus. Emerg. Infect. Dis. 20, 1347–1350. doi:
10.3201/eid2008.140526
Mesquita, J. R., Hakze-van der Honing, R., Almeida, A., Lourenco, M., van der
Poel, W. H., and Nascimento, M. S. (2015). Outbreak of porcine epidemic
diarrhea virus in Portugal, 2015. Transbound. Emer. Dis. 62, 586–588. doi:
10.1111/tbed.12409
Sato, T., Takeyama, N., Katsumata, A., Tuchiya, K., Kodama, T., and Kusanagi, K.
(2011). Mutations in the spike gene of porcine epidemic diarrhea virus
associated with growth adaptation in vitro and attenuation of virulence in vivo.
Virus Genes 43, 72–78. doi: 10.1007/s11262-011-0617-5
Sozzi, E., Luppi, A., Lelli, D., Martin, A. M., Canelli, E., Brocchi, E., et al. (2010).
Comparison of enzyme-linked immunosorbent assay and RT-PCR for the
detection of porcine epidemic diarrhea virus. Res. Vet. Sci. 1, 166–168. doi:
10.1016/j.rvsc.2009.05.009
Stadler, J., Zoels, S., Fux, R., Hanke, D., Pohlmann, A., Blome, S., et al. (2015).
Emergence of porcine epidemic diarrhea virus in Southern Germany. BMC Vet.
Res. 11:142. doi: 10.1186/s12917-015-0454-1
Stevenson, G. W., Hoang, H., Schwartz, K. J., Burrough, E. R., Sun, D., Madson, D.,
et al. (2013). Emergence of porcine epidemic diarrhea virus in the United States:
clinical signs, lesions, and viral genomic sequences. J. Vet. Diagn. Invest. 25,
649–654. doi: 10.1177/1040638713501675
Sun, D., Wang, X., Wei, S., Chen, J., and Feng, L. (2015). Epidemiology and vaccine
of porcine epidemic diarrhea virus in China: a mini-review. J. Vet. Med. Sci. 78,
355–363. doi: 10.1292/jvms.15-0446
Theuns, S., Conceição-Neto, N., Christiaens, I., Zeller, M., Desmarets, L. M. B.,
Roukaerts, I. D. M., et al. (2015). Complete genome sequence of a porcine
epidemic diarrhea virus from a novel outbreak in Belgium. Genome Announc.
3, e506–e515. doi: 10.1128/genomeA.00506-15
Thomas, J. T., Chen, Q., Gauger, P. C., Gimenez-Lirola, L. G., Sinha, A., Harmon,
K. M., et al. (2015). Effect of porcine epidemic diarrhea virus infectious doses
on infection outcomes in naive conventional neonatal and weaned pigs. PLoS
ONE 10:10. doi: 10.1371/journal.pone.0139266
University of Minnesota Veterinary Diagnostic Laboratory (2014). New Rapid
Semi-Quantitative RT-PCR Assay Developed to Detect Porcine Epidemic
Diarrhea Virus. Available at: https://www.cahfs.umn.edu/sites/cahfs.umn.edu/
files/rt-pcr-assay-veterinay-diagnostic-lab.pdf
Vlasova, A. N., Marthaler, D., Wang, Q., Culhane, M. R., Rossow, K. D., Rovira, A.,
et al. (2014). Distinct characteristics and complex evolution of PEDV strains,
North America, May 2013-February 2014. Emerg. Infec. Dis 20, 1620–1628.
doi: 10.3201/eid2010.140491
Wang, L., Zhang, Y., and Byrum, B. (2014). Development and evaluation of a
duplex real-time RT-PCR for detection and differentiation of virulent and
variant strains of porcine epidemic diarrhea viruses from the United States.
J. Virol. Methods 207, 154–157. doi: 10.1016/j.jviromet.2014.07.005
Yamamoto, R., Soma, J., Nakanishi, M., Yamaguchi, R., and Niinuma, S. (2015).
Isolation and experimental inoculation of an S INDEL strain of porcine
epidemic diarrhea virus in Japan. Res. Vet. Sci. 103, 103–106. doi: 10.1016/j.rvsc
.2015.09.024
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Bertasio, Giacomini, Lazzaro, Perulli, Papetti, Lavazza, Lelli,
Alborali and Boniotti. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 9 December 2016 | Volume 7 | Article 2009
